title: Therapies for onychomycosis a systematic review and network meta-analysis of mycological cure.
abstract: New therapies for onychomycosis continue to be developed, yet treatments are seldom directly compared in randomized controlled trials. The objective of this study was to compare the rates of mycological cure for oral and topical onychomycosis treatments using network meta-analysis. A systematic review of the literature on onychomycosis treatments published before March 25, 2013, was performed, and data were analyzed using network meta-analysis. Terbinafine, 250 mg, therapy was significantly superior to all treatments except itraconazole, 400 mg, pulse therapy; itraconazole, 200 mg, therapy was significantly superior to fluconazole and the topical treatments; and fluconazole, efinaconazole, ciclopirox, terbinafine nail solution, and amorolfine treatments were significantly superior to only placebo. These results support the superiority of 12-week continuous terbinafine, 250 mg, therapy and itraconazole, 400 mg, pulse therapy (1 week per month for 3 months) while suggesting the equivalence of topical therapies. These results reflect findings from the literature and treatment efficacy observed in clinical practice.
authors.forename: Aditya K
authors.initials: AK
authors.lastname: Gupta
authors.forename: Deanne
authors.initials: D
authors.lastname: Daigle
authors.forename: Maryse
authors.initials: M
authors.lastname: Paquet
mesh_terms: D006801:Humans; D000287:Administration, Topical; D000935:Antifungal Agents / Q000008:administration & dosage; D005533:Foot Dermatoses / Q000188:drug therapy; D014009:Onychomycosis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents